This course provides an overview of GLP regulations as they are applied and interpreted by the FDA, EPA and the Organization for Economic Cooperation and Development. Good Laboratory Practices (GLPs) ...

Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...

For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 receptor agonists like semaglutide and tirzepatide. Now, a phase 2 clinical ...

New data shows widespread undetected metabolic risk – even among “healthy” individuals – as Noom enables members to test, treat, and track progress from home Simple, at-home blood collection delivers ...

Biochemist Svetlana Mojsov, PhD, has been awarded the Frontiers of Knowledge Award in Biology and Biomedicine, presented by Spain’s BBVA Foundation, for her collaborative research with Daniel Drucker, ...

Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into ...

After months of successful weight loss, Eshaan Jain's progress had halted after switching to Wegovy. The food noise instantly came back after switching from Zepbound to Wegovy during a ...

Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor its ...

Samsung has teamed up with diabetes experts at Massachusetts General Hospital to see how Galaxy Watch 8 can help prevent muscle loss in GLP-1 patients.

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today announced the launch of its at-home Biomarkers Test Kit to Noom members in the United States, making ...